A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term ...

The presence of anti-CD4 autoantibodies in treatment-naive patients with advanced HIV was associated with a decreased rate of CD4 reconstitution following ART initiation.

The rate of fatal non–AIDS-defining cancers was 10 times lower in patients with CD4 counts >500 cells/mm 3 than in those with CD4 counts <50 cells/mm 3. Evidence is accumulating to indicate that ...

People with a CD4 count below 200 are considered to have AIDS and are more susceptible to opportunistic infections. In general, higher CD4 counts offer better protection and hint at a more robust ...

The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...

Two research teams led by Warner Greene at the Gladstone Institutes in San Francisco have demonstrated that the vast majority of CD4 T cells in lymphoid tissues, despite their ability to resist full ...

If they had a CD4 count above 500 at the start of follow-up they could expect to live to 80 and 78 years, respectively. If they also had a suppressed viral load, no AIDS diagnosis at the start of ...

Research on the presence of thyroid abnormalities in HIV showed that patients with HIV are at risk for developing a variety of thyroid disorders.

CD4-positive T cells are a subtype of lymphocyte. They are MHC class II-restricted and are important mediators of adaptive immunity. These cells are involved in both the induction and the ...

The researchers discovered that CD4 + Th1 cells, a type of immune cell, play a key role in targeting and eliminating dormant cancer cells. These cells, which can remain hidden in the body ...